Exomind vs ECT (Electroconvulsive Therapy)

rTMS and ECT are both brain stimulation treatments used for depression, but differ substantially in mechanism, invasiveness, and the specific clinical situations for which each is best suited.

rTMS uses focused magnetic pulses delivered to a fully conscious, awake patient without anaesthesia, and does not induce a seizure. ECT uses electrical current to deliberately induce a brief, controlled seizure under general anaesthesia, requiring a more involved medical procedure with anaesthetic monitoring.

ECT generally has higher response rates for the most severe forms of depression, including depression with psychotic features or high suicide risk requiring rapid intervention, whereas rTMS is typically used for treatment-resistant depression without these more acute, severe features.

ECT carries a recognised risk of short-term memory effects and requires anaesthesia-related recovery time, while rTMS does not involve anaesthesia and its most common side effects — scalp discomfort and headache — do not include the memory effects associated with ECT.

ECT is generally reserved for the most severe, urgent, or treatment-resistant presentations, including situations requiring rapid symptom control, while rTMS is well suited to patients with treatment-resistant depression who do not require this level of urgency and who prefer to avoid anaesthesia and its associated risks.

Dr. Muhammad Shoaib Zafar helps patients understand which treatment — rTMS, ECT, or another approach — best fits their specific clinical presentation.

This page is provided for general educational purposes and does not replace an individual psychiatric assessment.